XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating activities    
Net loss $ (55,059) $ (70,499)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 12,001 10,770
Depreciation and amortization 186 147
Amortization expense component of lease expense 969 496
Amortization of available-for-sale marketable securities, net 590 28
Realized gain on sale of available-for-sale marketable securities (39) (126)
Realized gain on sale of property and equipment (70)  
Deferred revenue   (21,751)
Changes in operating assets and liabilities:    
Income tax receivable 810 (436)
Other receivables (19,793) 509
Prepaid expenses 5,818 (1,391)
Accounts payable and accrued expenses (3,069) (4,608)
Operating lease liabilities (1,186) (714)
Net cash used in operating activities (58,842) (87,575)
Investing activities    
Proceeds from maturities of available-for-sale marketable securities 134,220 119,895
Proceeds from redemptions of available-for-sale marketable securities, at par 13,500 22,035
Proceeds from sale of available-for-sale marketable securities 10,029 23,148
Purchases of available-for-sale marketable securities (108,989) (21,016)
Proceeds from sale of property and equipment 70  
Purchases of property and equipment   (182)
Net cash provided by investing activities 48,830 143,880
Financing activities    
Proceeds from the exercise of stock options 1,320 671
Net cash provided by financing activities 1,320 671
Net (decrease) increase in cash, cash equivalents and restricted cash (8,692) 56,976
Cash, cash equivalents and restricted cash at beginning of period 32,091 18,713
Cash, cash equivalents and restricted cash at end of period 23,399 $ 75,689
Noncash investing and financing activities    
Stock subscription receivable from Vifor $ 44,969